Skip to main content
Fig. 3 | Biomarker Research

Fig. 3

From: Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications

Fig. 3

Applications of SCS in myeloma research. SCS has impacted various areas of cancer research and improved our understanding of clonal evolution, tumor heterogeneity, tumor microenvironment, therapeutic resistance in MM, which offers a profound opportunity to improve the diagnosis and identify biomarkers for precision medicine of MM. SCS: single-cell sequencing; MM: multiple myeloma; MGUS: monoclonal gammopathy of undetermined significance; SMM: smoldering multiple myeloma; RRMM: relapsed refractory multiple myeloma

Back to article page